课题基金 / 基金详情

PROGRESSIVE LUNG DISEASE AND SURFACTANT DYSFUNCTION WITH A DELETION OF SURFACT

PROGRESSIVE LUNG DISEASE AND SURFACTANT DYSFUNCTION WITH A DELETION OF SURFACT
进行性肺病和表面活性剂功能障碍(表面活性剂缺失)
批准号:
7355212
负责人:
AARON HAMVAS
金额:
$0.59万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-02-01 至 2007-01-31

项目摘要

项目成果

AARON HAMVAS的其他基金

相似基金

相关文献

中文摘要
翻译
这个子项目是利用由NIH/NCRR资助的中心拨款提供的资源的许多研究子项目之一。子项目和调查员(PI)可能从另一个NIH来源获得了主要资金,因此可能会出现在其他CRISE条目中。列出的机构是针对中心的,而不一定是针对调查员的机构。表面活性蛋白-C(SP-C)基因突变与家族性散发性间质性肺病(ILD)有关。这种突变的序列或肺表面活性物质的组成和功能还知之甚少。为了确定SP-C基因突变对肺表面活性物质的影响,我们在移植时从一名14个月大的进行性ILD婴儿身上获取肺组织。在一个等位基因上存在跨越SP-C基因91-93密码子UB外显子3的框架内9个碱基对缺失;亲本均未携带该缺失。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Mutations in the surfactant protein-C (SP-C) gene are responsible for familial a sporadic interstitial lung disease (ILD). The onsequences of such mutations or pulmonary surfactant composition and function are poorly understood. To determine the effects of a mutation in the SP-C gene on surfactant, we obtained lund tissue at the time of transplantation from a 14 month old infant with progressive ILD. An in-frame 9 base pair deletion spanning condons 91-93 ub Exon 3 of the SP-C gene was present on one allele; neither parent carried this deletion.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Neonatal Research Network: the Lurie Children's - Northwestern University Study Center
国内基金
海外基金
胚胎脑发育的分子机理:lgl2(late gestation lung 2)蛋白质的生物学功能的研究
  • 批准号:
    30470854
  • 项目类别:
    面上项目
  • 资助金额:
    18.0万元
  • 批准年份:
    2004
  • 负责人:
    陶涛
  • 依托单位: